Connect with us


Cardiolyse cardiac analytics platform wins NHS Digital Health Partnership Award

Avatar photo



Cardiolyse, a startup which provides seamless remote monitoring for post-discharged patients, is to pilot an NHS and Oxford University Hospital joint project via the ‘Monitoring cardiac conditions out of hospital’ category of the NHS Digital Health Partnership Award.

The Digital Health Partnership Award helps NHS organisations in England to bid for funding to accelerate the adoption of digital health technologies that support patients at home.

The awards are run by the Innovation Development Team, which is part of the Digital Care Models team in the Transformation Directorate; and bring together partners critical to the scaling of digital health technology. These include technology partners, patient activation and adoption and outcomes / benefits realisation.

Phase 2 launched in November and £5,518,492 was awarded across 27 projects to support people at home.

Among them is a project involving Cardiolyse, which addresses the challenge of patient follow-up after catheter ablation for atrial fibrillation, by obtaining ECGs in a safe, timely and less costly manner through an innovative technological solution.

Patients will have increased and more comprehensive monitoring of their cardiac condition out of hospital resulting in more timely interventions and avoiding potentially fatal cardiac events.

“Our primary goal here is to provide timely and data-driven insights both for cardiologists to support the more accurate diagnosticating approach and patients to improve their engagement and understanding of their post-discharged dynamics,” said Anna Starynska, co-founder and CEO at Cardiolyse.

Project details

The full impact of subsequent adoption of Cardiolyse will be felt in the following patient cohorts: all patients with newly diagnosed atrial fibrillation, patients following medical treatment or surgical treatment of atrial fibrillation.

There are 9,000 AF ablation procedures in England every year, and 1.4m patients live with AF, and they all need to be monitored for the rest of their life. 

Based on Cardiolyse’s partners’ capacity, including Arrhythmia Alliance UK, Cardiomyopathy, and the strong network of TheHill and Oxford University Hospital and its associated innovation catalyst The Hill, the project is expected to impact between 50,000 and 100,000 patients. 

In addition, patients with ischaemic strokes, compromised heart functionality and type 2 diabetes mellitus benefit from regular ECGs and are the next patient cohort to be targetted.

Established in 2016, Cardiolyse is a cloud cardiac analytics platform, that enables automatic electrocardiogram (ECG/EKG) interpretation for real-time remote heart health monitoring of post-discharged patients.

The solution is CE-certified for automatic detection of 19 types of Arrhythmias with its patented algorithms, standing behind the Universal ECG Score calculation and the Personal Baseline development.

It is a device-agnostic software solution developed for fast and seamless integration with almost any digital ECG device.

The product consists of a web dashboard and user-friendly Android and iOS applications with both doctor’s and patient interfaces.
The company’s headquarters are in Helsinki, Finland, with offices in London, UK.

Click here for more information or email: [email protected]


Collaborative Content:Healthcare accelerator

Continue Reading
1 Comment

1 Comment

  1. Pingback: Anne Cooper joins the Highland Marketing advisory board

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories